1. Home
  2. ALLR vs NCPL Comparison

ALLR vs NCPL Comparison

Compare ALLR & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLR
  • NCPL
  • Stock Information
  • Founded
  • ALLR 2004
  • NCPL 1984
  • Country
  • ALLR United States
  • NCPL United States
  • Employees
  • ALLR N/A
  • NCPL N/A
  • Industry
  • ALLR Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • ALLR Health Care
  • NCPL Finance
  • Exchange
  • ALLR Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • ALLR 4.0M
  • NCPL 4.3M
  • IPO Year
  • ALLR N/A
  • NCPL N/A
  • Fundamental
  • Price
  • ALLR $0.85
  • NCPL $2.68
  • Analyst Decision
  • ALLR
  • NCPL
  • Analyst Count
  • ALLR 0
  • NCPL 0
  • Target Price
  • ALLR N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • ALLR 564.1K
  • NCPL 187.9K
  • Earning Date
  • ALLR 08-04-2025
  • NCPL 07-28-2025
  • Dividend Yield
  • ALLR N/A
  • NCPL N/A
  • EPS Growth
  • ALLR N/A
  • NCPL N/A
  • EPS
  • ALLR N/A
  • NCPL N/A
  • Revenue
  • ALLR N/A
  • NCPL $812,612.00
  • Revenue This Year
  • ALLR N/A
  • NCPL N/A
  • Revenue Next Year
  • ALLR N/A
  • NCPL $101.16
  • P/E Ratio
  • ALLR N/A
  • NCPL N/A
  • Revenue Growth
  • ALLR N/A
  • NCPL N/A
  • 52 Week Low
  • ALLR $0.61
  • NCPL $1.41
  • 52 Week High
  • ALLR $17.35
  • NCPL $11.90
  • Technical
  • Relative Strength Index (RSI)
  • ALLR 39.03
  • NCPL 68.54
  • Support Level
  • ALLR $0.78
  • NCPL $2.13
  • Resistance Level
  • ALLR $0.93
  • NCPL $2.85
  • Average True Range (ATR)
  • ALLR 0.07
  • NCPL 0.26
  • MACD
  • ALLR -0.02
  • NCPL 0.06
  • Stochastic Oscillator
  • ALLR 18.72
  • NCPL 82.83

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: